Global Med Technologies(R) Now Providing Validation Services to Blood Banking Industry
November 06 2007 - 9:00AM
PR Newswire (US)
New Venture Utilizing PeopleMed(R), Inc. Subsidiary in Highly
Lucrative Previously Third-Party Market DENVER, Nov. 6
/PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc.
(OTC:GLOB) (BULLETIN BOARD: GLOB) , an international e-Health,
medical information technology company, announced today that its
PeopleMed, Inc. (PeopleMed) subsidiary will now be offering
complete validation and consulting services, primarily in the donor
center and hospital laboratory markets, to assist facilities with
the transition during software system implementation. The need for
validation and software consulting services is growing due to the
rapid adoption of new information technology within the healthcare
space. Prior to entering this business, the Company referred
customers to various third-party providers for these services.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)
Global Med Technologies' Wyndgate Technologies(R) (Wyndgate)
division manufactures medical device software for use in blood
donor centers and hospital transfusion services. The United States
Food and Drug Administration (FDA) and other regulatory agencies
require that, as medical devices, Wyndgate's products must be
validated before being used to manage the blood supply.
Increasingly, blood center and transfusion staffs are short-handed
and struggle to meet daily workload. It is difficult to add
validation requirements to this burden for short-staffed
facilities. This trend has grown over the past few years, creating
added demand for Global Med Technologies' services. This demand
prompted the Company to realign its PeopleMed subsidiary's business
operation to meet the increasing needs of customers for validation
services. Additionally, blood donor center and hospital transfusion
service clients of the Company's Wyndgate division are increasingly
in need of expert assistance with Standard Operating Procedures
(SOPs), independent software validation, upload of data converted
from legacy systems and other consulting services. PeopleMed
fulfills this demand by helping clients to better and more
efficiently utilize Wyndgate's SafeTrace(R), SafeTrace Tx(R), and
El Dorado Donor Doc(TM) products. Tom Marcinek, President and COO
of Global Med Technologies, Inc., stated, "The establishment of
this new service within the PeopleMed subsidiary allows customers
to obtain assistance from the experts who know the Company's
products best while maintaining independent objectivity as a
separate business unit distinct from Wyndgate Technologies'
operations. Customers have been asking us for these services for
some time." Mr. Marcinek further stated, "Offering these services
through our PeopleMed subsidiary allows us to maintain objective
independence from the Wyndgate division operation and provide
confidence that all services are provided by the most qualified,
knowledgeable experts who are a part of the Global Med
Technologies' family of companies. Our goal is to provide a level
of service and efficiency that exceeds current offerings in the
marketplace." PeopleMed's service offerings are not limited to
Wyndgate's products, nor are they restricted to the template,
off-the-shelf services common among third-party providers today.
PeopleMed offers a full menu of choices combined with consulting
services to help ease the transition of system implementation. This
independent objectivity, combined with the expert knowledge of
Global Med Technologies' resources and the unparalleled
coordination with the Wyndgate implementation team, will better
allow customers to move forward with confidence as they implement
new software solutions. About Global Med Technologies, Inc. Global
Med Technologies(R), Inc. is an international e-Health medical
information technology company providing information management
software products and services to the healthcare industry. Its
Wyndgate Technologies(R) division is a leading supplier of
information management systems to U.S. and international blood
centers and hospital transfusion centers. Each year, Wyndgate's
products and services manage more than eight million blood
components, representing over 27% of the U.S. blood supply.
Wyndgate's products are also being used in Canada and sub-Saharan
Africa, and are being implemented in the Caribbean. Together, the
Donor Doc(TM) interactive donor health history questionnaire,
SafeTrace(R) donor management system, and the SafeTrace Tx(R)
advanced transfusion management system, recently patented, provide
Vein-to-Vein(R) tracking from donor collection to patient
transfusion. For more information about Global Med's products and
services, please call 800-WYNDGATE or visit
http://www.globalmedtech.com/ , http://www.peoplemed.com/ and
http://www.wyndgate.com/. This news release may include statements
that constitute forward-looking statements, usually containing the
words "believe," "estimate," "project," "expects" or similar
expressions. These statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGODATASOURCE:
Global Med Technologies, Inc. CONTACT: Company, Michael I. Ruxin,
M.D. of Global Med Technologies, Inc., +1-303-238-2000, ; or
Investors, Paul Holm of H.L. Lanzet, Inc., +1-212-888-4570, Web
site: http://www.globalmedtech.com/
Copyright